Insider Selling: Viemed Healthcare (NASDAQ:VMD) Director Sells $230,000.00 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Timothy Smokoff sold 20,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares of the company’s stock, valued at $868,457. This represents a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $11.63 on Monday. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. Viemed Healthcare, Inc. has a 12 month low of $5.93 and a 12 month high of $11.88. The company has a 50-day moving average price of $9.91 and a 200 day moving average price of $8.85. The company has a market cap of $445.89 million, a price-to-earnings ratio of 31.43 and a beta of 1.12.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). The business had revenue of $75.41 million for the quarter, compared to analysts’ expectations of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. As a group, equities research analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Institutional Trading of Viemed Healthcare

Several hedge funds have recently modified their holdings of VMD. State of Alaska Department of Revenue acquired a new stake in shares of Viemed Healthcare in the 4th quarter worth $25,000. Kemnay Advisory Services Inc. acquired a new position in Viemed Healthcare during the 4th quarter valued at about $46,000. Quarry LP acquired a new position in Viemed Healthcare during the 3rd quarter valued at about $48,000. AQR Capital Management LLC purchased a new position in shares of Viemed Healthcare in the 1st quarter valued at approximately $90,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Viemed Healthcare during the fourth quarter worth $101,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.